tiprankstipranks
Trending News
More News >
Astera Labs, Inc. (ALAB)
NASDAQ:ALAB
US Market
Advertisement

Astera Labs, Inc. (ALAB) AI Stock Analysis

Compare
2,479 Followers

Top Page

ALAB

Astera Labs, Inc.

(NASDAQ:ALAB)

Rating:68Neutral
Price Target:
$190.00
▲(2.23% Upside)
Astera Labs' overall stock score is driven by strong financial performance and positive earnings call highlights, indicating growth potential. However, high valuation metrics and increased operating expenses present risks. The technical analysis suggests bullish momentum, but caution is warranted due to overbought signals.
Positive Factors
AI Infrastructure Investment
The faster ramp-up of its new Scorpio P-series switch helped drive upside in the quarter, while management’s commentary on X-series engagement across ten different customers increases confidence in Astera’s position as a leading provider of high-value connectivity solutions.
Market Position
Astera Labs is a rapidly growing share gainer in the connectivity chip market.
Product Growth
Astera Labs posted another significant beat and raise, driven by growth across Scorpio, Aries, and Taurus.
Negative Factors
Earnings Pressure
Despite the strong top-line guidance, non-GAAP EPS were guided to decrease sequentially in the third quarter, pressured by a higher effective tax rate of 20%.
Stock Price Volatility
The setup going into the quarter has become more challenging, with the stock up 25% over the last month.
Stock Valuation Concerns
There are concerns about increased customer concentration from more AMZN impacting the company's valuation multiple.

Astera Labs, Inc. (ALAB) vs. SPDR S&P 500 ETF (SPY)

Astera Labs, Inc. Business Overview & Revenue Model

Company DescriptionAstera Labs, Inc. designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale. The company was incorporated in 2017 and is based in Santa Clara, California.
How the Company Makes MoneyAstera Labs generates revenue through the sale of its semiconductor products and solutions, which are specifically designed to enhance data connectivity in complex computing environments. The company's key revenue streams include the sale of high-speed connectivity chips and modules that facilitate efficient data transfer and communication within data centers and cloud infrastructures. Additionally, Astera Labs may engage in strategic partnerships with major technology companies to integrate its solutions into larger systems, further driving sales and market penetration. The company's earnings are significantly influenced by the growing demand for advanced data processing and storage solutions in sectors such as AI, machine learning, and cloud computing.

Astera Labs, Inc. Earnings Call Summary

Earnings Call Date:Aug 05, 2025
(Q2-2025)
|
% Change Since: 37.12%|
Next Earnings Date:Nov 10, 2025
Earnings Call Sentiment Positive
The earnings call presented strong financial performance with significant revenue growth, successful ramp of the Scorpio P-Series, and strategic partnerships enhancing the competitive positioning. However, the increase in operating expenses and a higher tax rate for Q3 present some financial challenges.
Q2-2025 Updates
Positive Updates
Significant Revenue Growth
Quarterly revenue of $191.9 million was up 20% from the prior quarter and up 150% versus Q2 of last year. This growth was driven by both signal conditioning and switch fabric product lines.
Scorpio P-Series Success
The Scorpio P-Series exceeded 10% of total revenue, making it the fastest ramping product line in Astera Labs' history.
Strategic Partnerships
Expanded partnerships with NVIDIA, Alchip Technologies, and AMD, indicating strong ecosystem integration and collaboration on AI infrastructure.
Non-GAAP Financial Performance
Non-GAAP gross margin was 76%, up 110 basis points, and non-GAAP operating margin was 39.2%, up 550 basis points from the previous quarter.
Negative Updates
Increased Operating Expenses
Non-GAAP operating expenses for Q2 were $70.7 million, up roughly $5 million from the previous quarter, driven by continued scaling in R&D.
High Tax Rate for Q3
Non-GAAP tax rate for Q3 was expected to be 20%, reflecting the impact of a recent change in tax law.
Company Guidance
During the Astera Labs Second Quarter 2025 Earnings Conference Call, the company provided guidance for the upcoming fiscal quarter. Astera Labs expects Q3 2025 revenue to range between $203 million and $210 million, representing a 6% to 9% increase from the previous quarter's revenue of $191.9 million. The growth is anticipated to be driven by the Aries, Taurus, and Scorpio product lines, with Scorpio P-Series solutions continuing to be a significant contributor. The company projects a non-GAAP gross margin of approximately 75%, while non-GAAP operating expenses are expected to be between $76 million and $80 million. Interest income is forecasted at $10 million, with a non-GAAP tax rate of around 20%, reflecting a recent change in tax law. This results in an expected non-GAAP fully diluted earnings per share of $0.38 to $0.39 for the third quarter.

Astera Labs, Inc. Financial Statement Overview

Summary
Astera Labs is experiencing rapid revenue growth and maintains a solid balance sheet with low leverage. However, profitability remains a concern with negative profit margins and return on equity. The positive shift in free cash flow is a favorable indicator, suggesting potential for improved financial health.
Income Statement
65
Positive
Astera Labs has shown a strong revenue growth of 242% from 2023 to 2024. Despite the impressive revenue growth, the company is still not profitable with negative net and EBIT margins, indicating ongoing operational challenges.
Balance Sheet
70
Positive
The balance sheet is robust with a high equity ratio of 91.5% and low debt, evidenced by a debt-to-equity ratio of 0.001. However, the negative ROE of -8.65% highlights inefficiencies in generating profits from shareholders' equity.
Cash Flow
75
Positive
Astera Labs has improved its cash flow situation significantly, with free cash flow turning positive in 2024. The operating cash flow to net income ratio is strong at -1.64, indicating effective cash management despite net losses.
BreakdownTTMDec 2024Dec 2023Dec 2022
Income Statement
Total Revenue605.55M396.29M115.79M79.87M
Gross Profit457.30M302.70M79.83M58.68M
EBITDA46.65M-112.91M-27.72M-59.39M
Net Income100.16M-83.42M-26.26M-58.34M
Balance Sheet
Total Assets1.27B1.05B196.29M211.73M
Cash, Cash Equivalents and Short-Term Investments1.07B914.30M149.31M163.14M
Total Debt32.31M1.29M2.93M1.96M
Total Liabilities135.69M89.71M38.87M41.90M
Stockholders Equity1.14B964.80M157.43M169.84M
Cash Flow
Free Cash Flow210.37M102.43M-15.48M-39.77M
Operating Cash Flow249.08M136.68M-12.72M-35.90M
Investing Cash Flow-518.48M-757.57M-17.77M-90.59M
Financing Cash Flow11.73M655.84M-502.00K151.67M

Astera Labs, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price185.85
Price Trends
50DMA
115.31
Positive
100DMA
94.19
Positive
200DMA
97.40
Positive
Market Momentum
MACD
23.24
Negative
RSI
75.34
Negative
STOCH
85.98
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ALAB, the sentiment is Positive. The current price of 185.85 is above the 20-day moving average (MA) of 149.05, above the 50-day MA of 115.31, and above the 200-day MA of 97.40, indicating a bullish trend. The MACD of 23.24 indicates Negative momentum. The RSI at 75.34 is Negative, neither overbought nor oversold. The STOCH value of 85.98 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ALAB.

Astera Labs, Inc. Risk Analysis

Astera Labs, Inc. disclosed 65 risk factors in its most recent earnings report. Astera Labs, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Astera Labs, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$11.19B30.036.61%3.76%-8.24%-48.31%
68
Neutral
$31.70B325.8810.11%163.80%
63
Neutral
$21.11B47.675.72%-17.93%-75.83%
58
Neutral
$9.34B138.48-5.96%33.50%-197.38%
57
Neutral
$4.37B-9.71%29.66%47.97%
56
Neutral
$6.72B7.77-9.67%6.24%14.98%-4.62%
55
Neutral
$5.90B-9.17%65.12%15.46%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ALAB
Astera Labs, Inc.
185.85
144.76
352.30%
MTSI
MACOM Technology Solutions Holdings
123.09
16.88
15.89%
ON
ON Semiconductor
51.09
-26.63
-34.26%
SLAB
Silicon Laboratories
130.67
23.12
21.50%
SWKS
Skyworks Solutions
74.52
-29.81
-28.57%
SITM
SiTime Corporation
221.44
79.26
55.75%

Astera Labs, Inc. Corporate Events

Executive/Board ChangesShareholder Meetings
Astera Labs Holds 2025 Annual Stockholders Meeting
Positive
Jun 10, 2025

Astera Labs, Inc. conducted its 2025 Annual Stockholders Meeting on June 5, 2025, where 144,451,882 shares were voted. During the meeting, stockholders elected three Class I directors to the board and ratified PricewaterhouseCoopers LLP as the company’s independent auditor for the fiscal year ending December 31, 2025. These decisions are expected to influence the company’s governance and financial oversight positively.

The most recent analyst rating on (ALAB) stock is a Buy with a $60.00 price target. To see the full list of analyst forecasts on Astera Labs, Inc. stock, see the ALAB Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 07, 2025